Chanimec 0.8 mg/ml Oral Solution for Sheep

País: Reino Unido

Idioma: inglés

Fuente: VMD (Veterinary Medicines Directorate)

Ingredientes activos:

Ivermectin

Disponible desde:

Chanelle Pharmaceuticals Manufacturing Ltd

Código ATC:

QP54AA01

Designación común internacional (DCI):

Ivermectin

formulario farmacéutico:

Oral solution

tipo de receta:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Grupo terapéutico:

Sheep

Área terapéutica:

Endectocide

Estado de Autorización:

Authorized

Fecha de autorización:

2010-07-08

Ficha técnica

Revised: November 2014
AN. 01418/2013
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
CHANIMEC 0.8 mg/ml Oral Solution for Sheep
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Each ml contains:
Ivermectin
0.8mg
EXCIPIENT(S):
Benzyl Alcohol (E1519)
28.6mg
Butylhydroxyanisole (E320)
0.10 mg
Propyl Gallate (E310)
0.10 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral Solution.
A transparent, yellow coloured solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
- Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of infections with the following parasites:
NEMATODES
GASTROINTESTINAL ROUNDWORMS (adult and fourth larval stage)
_Haemonchus contortus_
_Teladorsagia circumcincta_
_Trichostrongylus _spp.
_Cooperia _spp.
Revised: November 2014
AN. 01418/2013
Page 2 of 8
_Nematodirus _spp.
Including _N. battus_
_Strongyloides papillosus_
_Chabertia ovina_
LUNGWORMS(adult and fourth larval stage)
_Dictyocaulus filaria_
ARTHROPODS
NASAL BOT (all larval stages)
_Oestrus ovis_
4.3
CONTRAINDICATIONS
Do
not
use
in
animals
with
known
hypersensitivity
to
the
active
ingredient or any of the excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk of development of resistance and could ultimately
result in ineffective therapy:
•
Too frequent and repeated use of anthelmintics from the same
class, over an extended period of time.
•
Underdosing, which may be due to underestimation of body
weight or misadministration of the product.
Resistance
to
ivermectin
(an
avermectin)
has
been
reported
in
_Teladorsagia _ in sheep and goats within the EU and it is common in
_Haemonchus_ in sheep outside the EU. Therefore the use of this
product
should be based on local (regional, farm) epidemiological information
about susceptibility of nematode and recommendations on how to limit
further selection for resistance to anthelmintics.
Suspected clinical